Kerrie Elizabeth Wiley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kerrie Elizabeth Wiley has a total of 180 co-authors. Here are the top co-authors by number of shared publications:
- Julie Leask
University of Sydney
18 shared publications - Amani Salem Alqahtani
Saudi Food and Drug Authority, Riyadh 13513, Saudi Arabia
12 shared publications - Katie Attwell
School of Social Sciences, The University of Western Australia, Perth, Western Australia, Australia
6 shared publications Anita E. Heywood
School of Public Health and Community Medicine, The University of New South Wales, Australia, Sydney, New South Wales, Australia
5 shared publications- Anita Elizabeth Heywood
School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Kensington, NSW, 2052, Australia
5 shared publications - Chris Degeling
University of Wollongong
5 shared publications
Latest Publications
- 7 October 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (3) , 1089-1091
Vaccinating women across the life course: Gendered social norms, obligations and vaccine uptake
- 7 October 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (3) , 1089-1091
Vaccinating women across the life course: Gendered social norms, obligations and vaccine uptake
- Open Access
- 28 July 2026
- Published by Wiley in Reviews in Aquaculture
- Vol. 18 (4) , e70193
High‐Throughput Sequencing in Aquaculture Disease Investigations: Challenges and Opportunities for Implementation
The current generation of sequencing technologies can produce terabases of data with exceptional accuracy and speed, at a fraction of the cost of older methods. Despite this unprecedented power, adoption into aquaculture health management presents several challenges, including identifying where such capability may be optimally deployed. Here we synthesise discussions from a structured expert workshop held at the 2025 Aotearoa Aquatic Diseases Symposium in Dunedin, New Zealand, where experts from industry, government and academia explored the challenges and opportunities for adopting high‐throughput sequencing (HTS) to support disease investigations in aquaculture. Workshop participants identified key applications for HTS, including pathogen discovery during unexplained mortality events and source attribution in epidemics, but also noted technical, regulatory and social challenges for widespread adoption. These include the need for standardised sampling and bioinformatic workflows, data sovereignty, equitable access to the technology and uncertainty around interpreting detection of notifiable pathogens. Targeted research and coordinated regulatory frameworks will be essential to guide responsible use of HTS and determine where it adds value relative to existing approaches. Clarifying these opportunities and constraints will guide the responsible adoption of HTS into aquaculture health management to support sustainable growth for the sector.
- 28 July 2026
- Published by Wiley in Reviews in Aquaculture
- Vol. 18 (4) , e70193
Open AccessHigh‐Throughput Sequencing in Aquaculture Disease Investigations: Challenges and Opportunities for Implementation
The current generation of sequencing technologies can produce terabases of data with exceptional accuracy and speed, at a fraction of the cost of older methods. Despite this unprecedented power, adoption into aquaculture health management presents several challenges, including identifying where such capability may be optimally deployed. Here we synthesise discussions from a structured expert workshop held at the 2025 Aotearoa Aquatic Diseases Symposium in Dunedin, New Zealand, where experts from industry, government and academia explored the challenges and opportunities for adopting high‐throughput sequencing (HTS) to support disease investigations in aquaculture. Workshop participants identified key applications for HTS, including pathogen discovery during unexplained mortality events and source attribution in epidemics, but also noted technical, regulatory and social challenges for widespread adoption. These include the need for standardised sampling and bioinformatic workflows, data sovereignty, equitable access to the technology and uncertainty around interpreting detection of notifiable pathogens. Targeted research and coordinated regulatory frameworks will be essential to guide responsible use of HTS and determine where it adds value relative to existing approaches. Clarifying these opportunities and constraints will guide the responsible adoption of HTS into aquaculture health management to support sustainable growth for the sector.
- Open Access
Australians' attitudes to mRNA vaccination in humans and animals: A cross-sectional survey
- Open Access
- 21 April 2026
- Published by Elsevier in SSRN Electronic Journal
A systematic review of knowledge, attitudes, and behaviour towards Japanese Encephalitis vaccination
Introduction: Three billion people globally are at risk of Japanese Encephalitis (JE), a mosquito-borne disease primarily spread by Culex mosquitoes. Despite the availability of a cost-effective vaccine, uptake is limited and a deeper understanding of people’s knowledge, attitudes, and behaviours (KABs) towards JE vaccine is needed to improve this. This study systematically reviewed the existing research on KABs towards JE vaccination, with a view to informing JE vaccine program delivery, policy and practice.Methods: Seven bibliometric databases, grey literature and references of included studies were searched for primary studies on KABs towards JE vaccination. Search outputs were independently screened; data were extracted and synthesised descriptively.Results: Of the 26 studies included, most were conducted in JE endemic countries and examined four participant groups: travellers from non-endemic settings, caregivers of vaccine recipients and non-traveller adults from endemic settings, and vaccine providers/advocates from both settings. Of the few studies, adult vaccine recipients had low knowledge and awareness of the vaccine, whereas caregivers’ knowledge and awareness were higher. Attitudes toward JE vaccination were generally positive and KABs were often influenced by health workers, community leaders, risk perception, cost, time constraints, migration, and vaccine availability and accessibility.Conclusion:There is limited information on KABs regarding JE vaccination in both endemic and non-endemic countries. This review highlights the barriers of JE vaccination and the role of health professionals and vaccine advocates in JE vaccination programs. Focusing on empowering these groups is key to increasing JE vaccine uptake across different populations.
- 21 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessA systematic review of knowledge, attitudes, and behaviour towards Japanese Encephalitis vaccination
Introduction: Three billion people globally are at risk of Japanese Encephalitis (JE), a mosquito-borne disease primarily spread by Culex mosquitoes. Despite the availability of a cost-effective vaccine, uptake is limited and a deeper understanding of people’s knowledge, attitudes, and behaviours (KABs) towards JE vaccine is needed to improve this. This study systematically reviewed the existing research on KABs towards JE vaccination, with a view to informing JE vaccine program delivery, policy and practice.Methods: Seven bibliometric databases, grey literature and references of included studies were searched for primary studies on KABs towards JE vaccination. Search outputs were independently screened; data were extracted and synthesised descriptively.Results: Of the 26 studies included, most were conducted in JE endemic countries and examined four participant groups: travellers from non-endemic settings, caregivers of vaccine recipients and non-traveller adults from endemic settings, and vaccine providers/advocates from both settings. Of the few studies, adult vaccine recipients had low knowledge and awareness of the vaccine, whereas caregivers’ knowledge and awareness were higher. Attitudes toward JE vaccination were generally positive and KABs were often influenced by health workers, community leaders, risk perception, cost, time constraints, migration, and vaccine availability and accessibility.Conclusion:There is limited information on KABs regarding JE vaccination in both endemic and non-endemic countries. This review highlights the barriers of JE vaccination and the role of health professionals and vaccine advocates in JE vaccination programs. Focusing on empowering these groups is key to increasing JE vaccine uptake across different populations.
- Open Access
- 29 January 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 393, 119037
A critical analysis of the Australian public consultation on childhood vaccine mandate introduction
- 29 January 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 393, 119037
Open AccessA critical analysis of the Australian public consultation on childhood vaccine mandate introduction
- Open Access
Joint human and animal vaccination strategies to reach mobile pastoralists and their livestock in Africa: A scoping review
Background: Africa’s pastoralist population is approximately 268 million, which is over a quarter of the continent’s population. They occupy more than 40% of Africa’s land, though density varies by country. Mobile pastoralists are often underreported in national censuses due to political marginalisation and difficulties in counting these groups. Vaccination services delivered through fixed facilities do not adequately reach mobile pastoralists, which impacts vaccination coverage and health outcomes for these mobile groups who are economically and culturally connected to their livestock. This scoping review explored literature on joint human-animal vaccination strategies as a One Health approach to improve vaccination coverage among these mobile pastoralists and their animals. Methods: A systematic search was performed across 12 databases, following the Joanna Briggs Institute (JBI) methodology and adhering to the PRISMA-ScR reporting guidelines. Results: Of 2469 records screened for eligibility, 17 articles were included in a full-text assessment, and five met the eligibility criteria. The included studies were published between 2004 and 2016. Three studies were conducted in Chad and one each in Nigeria and Somalia. The implementation of the vaccination campaigns was organised in three phases: planning, implementation, and post-vaccination. Key enabling factors were identified in these joint campaigns, including the use of a participatory approach throughout both the planning and implementation phases, with a strong emphasis on intersectoral collaboration and active community engagement in all activities. Interventions were adapted during the campaigns to ensure they were contextually acceptable. The joint human and animal vaccination campaigns increased vaccination coverage among mobile pastoralists compared to baseline levels by targeting children, women of reproductive age, and their animals. Nevertheless, the campaigns highlighted human vaccination results but paid little attention to animal populations, contradicting the values of mobile pastoralists. Conclusions: This review offers valuable insights into the design of joint vaccination campaigns tailored for mobile pastoralists and their livestock. Whilst joint vaccination campaigns appear to improve human vaccine uptake, more information is needed to evaluate the potential benefits that could be gained by attention to animal vaccination and improved animal health outcomes, which could further improve non-vaccine-related human health outcomes.
Open AccessJoint human and animal vaccination strategies to reach mobile pastoralists and their livestock in Africa: A scoping review
Background: Africa’s pastoralist population is approximately 268 million, which is over a quarter of the continent’s population. They occupy more than 40% of Africa’s land, though density varies by country. Mobile pastoralists are often underreported in national censuses due to political marginalisation and difficulties in counting these groups. Vaccination services delivered through fixed facilities do not adequately reach mobile pastoralists, which impacts vaccination coverage and health outcomes for these mobile groups who are economically and culturally connected to their livestock. This scoping review explored literature on joint human-animal vaccination strategies as a One Health approach to improve vaccination coverage among these mobile pastoralists and their animals. Methods: A systematic search was performed across 12 databases, following the Joanna Briggs Institute (JBI) methodology and adhering to the PRISMA-ScR reporting guidelines. Results: Of 2469 records screened for eligibility, 17 articles were included in a full-text assessment, and five met the eligibility criteria. The included studies were published between 2004 and 2016. Three studies were conducted in Chad and one each in Nigeria and Somalia. The implementation of the vaccination campaigns was organised in three phases: planning, implementation, and post-vaccination. Key enabling factors were identified in these joint campaigns, including the use of a participatory approach throughout both the planning and implementation phases, with a strong emphasis on intersectoral collaboration and active community engagement in all activities. Interventions were adapted during the campaigns to ensure they were contextually acceptable. The joint human and animal vaccination campaigns increased vaccination coverage among mobile pastoralists compared to baseline levels by targeting children, women of reproductive age, and their animals. Nevertheless, the campaigns highlighted human vaccination results but paid little attention to animal populations, contradicting the values of mobile pastoralists. Conclusions: This review offers valuable insights into the design of joint vaccination campaigns tailored for mobile pastoralists and their livestock. Whilst joint vaccination campaigns appear to improve human vaccine uptake, more information is needed to evaluate the potential benefits that could be gained by attention to animal vaccination and improved animal health outcomes, which could further improve non-vaccine-related human health outcomes.
- Open Access
- 23 April 2025
- Published by Wiley in Medical Journal of Australia
- Vol. 223 (3) , 117-119
Optimising our response to a potential H5N1 avian influenza pandemic: preparing to protect people working at the human–animal interface
- 23 April 2025
- Published by Wiley in Medical Journal of Australia
- Vol. 223 (3) , 117-119
Open AccessOptimising our response to a potential H5N1 avian influenza pandemic: preparing to protect people working at the human–animal interface
- Open Access
The Relationship Between Postpartum Depression and Timely Child Vaccination: A Systematic Review
Background/Objective: Vaccines administered during early childhood rely on caregivers being aware, willing, and able to vaccinate their child. Postpartum depression (PPD) could adversely affect a parent’s ability to undertake such preventive care. This systematic review sought to examine the relationship between PPD and timely vaccination in children. Methods: We systematically searched eight databases (MEDLINE ALL, Embase, PsycINFO, CINAHL, LILACS, Web of Science, Sociological Abstracts, and Scopus) from database inception to September 2023. We also reviewed reference lists of included studies. We included primary studies that examined the association between PPD and child vaccination status between birth and 24 months. Two researchers independently extracted data and assessed study quality. Results: In total, 5504 records were screened for eligibility. Of the 50 articles included in full-text assessment, 12 met the eligibility criteria. Most studies (83%) were conducted in high-income countries, with a minority (17%) from lower-middle income countries (LMICs). The sample size of studies varied from 450,000 participants (17%). Overall, six studies (50%) found a relationship between maternal PPD and child vaccinations not completed on time, and six (50%) found no relationship. In most studies that were assessed to be of high-quality and found a relationship, the magnitude of the absolute risk was small. Conclusions: We detected significant heterogeneity among the included studies. Further high-quality research using standardized definitions is needed to determine whether parents with PPD may require tailored strategies and supports that consider their symptoms and specific barriers to vaccination.
Open AccessThe Relationship Between Postpartum Depression and Timely Child Vaccination: A Systematic Review
Background/Objective: Vaccines administered during early childhood rely on caregivers being aware, willing, and able to vaccinate their child. Postpartum depression (PPD) could adversely affect a parent’s ability to undertake such preventive care. This systematic review sought to examine the relationship between PPD and timely vaccination in children. Methods: We systematically searched eight databases (MEDLINE ALL, Embase, PsycINFO, CINAHL, LILACS, Web of Science, Sociological Abstracts, and Scopus) from database inception to September 2023. We also reviewed reference lists of included studies. We included primary studies that examined the association between PPD and child vaccination status between birth and 24 months. Two researchers independently extracted data and assessed study quality. Results: In total, 5504 records were screened for eligibility. Of the 50 articles included in full-text assessment, 12 met the eligibility criteria. Most studies (83%) were conducted in high-income countries, with a minority (17%) from lower-middle income countries (LMICs). The sample size of studies varied from 450,000 participants (17%). Overall, six studies (50%) found a relationship between maternal PPD and child vaccinations not completed on time, and six (50%) found no relationship. In most studies that were assessed to be of high-quality and found a relationship, the magnitude of the absolute risk was small. Conclusions: We detected significant heterogeneity among the included studies. Further high-quality research using standardized definitions is needed to determine whether parents with PPD may require tailored strategies and supports that consider their symptoms and specific barriers to vaccination.
- Open Access
- 26 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1) , 9880670
Scoping Review of Japanese Encephalitis Virus Transmission Models
Japanese encephalitis virus (JEV) causes ~100,000 clinical cases and 25,000 deaths annually worldwide, mainly in Southeast Asia and the Western Pacific and mostly in children. JEV is transmitted to humans through the bite of mosquitoes that have fed on competent hosts. Abiotic factors, such as seasonal rainfall, influence transmission. Transmission models have an important role in understanding disease dynamics and developing prevention and control strategies to limit the impact of infectious diseases. Our goal was to investigate how transmission models capture JEV infection dynamics and their role in predicting and controlling infection. This was achieved by identifying published JEV transmission models, describing their features and identifying their limitations, to guide future modelling. A Preferred Reporting Items for Systematic Reviews and Meta‐Analyses Extension for Scoping Reviews (PRISMA‐ScR)‐guided scoping review of peer‐reviewed JEV transmission models was conducted. Databases searched included PubMed, ProQuest, Scopus, Web of Science and Google Scholar. Of the 881 full‐text papers available in English, 29 were eligible for data extraction. Publication year ranged from 1975 to 2023. The median number of host populations represented in each model was 3 (range: 1–8; usually humans, mosquitoes and pigs). Most (72% [ n = 21]) models were deterministic, using ordinary differential equations to describe transmission. Ten models were applied (representing a real JEV transmission setting) and validated with field data, while the remaining 19 models were theoretical. In the applied models, data from only a small proportion of countries in Southeast Asia and the Western Pacific were used. Limitations included gaps in knowledge of local JEV epidemiology, vector attributes and the impact of prevention and control strategies, along with a lack of model validation with field data. The lack and limitations of models highlight that further research to understand JEV epidemiology is needed and that there is opportunity to develop and implement applied models to improve control strategies for at‐risk populations of animals and humans.
- 26 January 2025
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 2025 (1) , 9880670
Open AccessScoping Review of Japanese Encephalitis Virus Transmission Models
Japanese encephalitis virus (JEV) causes ~100,000 clinical cases and 25,000 deaths annually worldwide, mainly in Southeast Asia and the Western Pacific and mostly in children. JEV is transmitted to humans through the bite of mosquitoes that have fed on competent hosts. Abiotic factors, such as seasonal rainfall, influence transmission. Transmission models have an important role in understanding disease dynamics and developing prevention and control strategies to limit the impact of infectious diseases. Our goal was to investigate how transmission models capture JEV infection dynamics and their role in predicting and controlling infection. This was achieved by identifying published JEV transmission models, describing their features and identifying their limitations, to guide future modelling. A Preferred Reporting Items for Systematic Reviews and Meta‐Analyses Extension for Scoping Reviews (PRISMA‐ScR)‐guided scoping review of peer‐reviewed JEV transmission models was conducted. Databases searched included PubMed, ProQuest, Scopus, Web of Science and Google Scholar. Of the 881 full‐text papers available in English, 29 were eligible for data extraction. Publication year ranged from 1975 to 2023. The median number of host populations represented in each model was 3 (range: 1–8; usually humans, mosquitoes and pigs). Most (72% [ n = 21]) models were deterministic, using ordinary differential equations to describe transmission. Ten models were applied (representing a real JEV transmission setting) and validated with field data, while the remaining 19 models were theoretical. In the applied models, data from only a small proportion of countries in Southeast Asia and the Western Pacific were used. Limitations included gaps in knowledge of local JEV epidemiology, vector attributes and the impact of prevention and control strategies, along with a lack of model validation with field data. The lack and limitations of models highlight that further research to understand JEV epidemiology is needed and that there is opportunity to develop and implement applied models to improve control strategies for at‐risk populations of animals and humans.
- Open Access
- 3 June 2024
- Published by Wiley in Health Promotion Journal of Australia
- Vol. 36 (1)
Evidence gaps and challenges in maintaining and increasing vaccine uptake: A Delphi survey with Australian stakeholders
Issue Addressed: Increasing and maintaining vaccination uptake is crucial for preventing and managing infectious diseases. In the context of the post‐coronavirus disease 2019 (COVID‐19) pandemic landscape, this paper examines the perceptions of immunisation implementers and policymakers to uncover the challenges and evidence gaps in routine immunisation efforts.Methods: We conducted an online two‐round modified Delphi survey with immunisation experts, senior public servants, policymakers, policy advisory groups, and representatives from peak bodies from across Australia. We asked respondents to outline what they see as the greatest challenges to increasing and maintaining uptake of recommended vaccines in Australia; the most difficult aspects of their work in vaccination; the largest evidence gaps in vaccine uptake; and the kinds of social and behavioural research they would like to see prioritised.Results: The two most important challenges for increasing and maintaining vaccine uptake were effectively communicating the benefits of vaccines to parents and the public and ensuring accessible and affordable vaccination services. Participants strongly agreed that ‘communication about the importance of vaccination’ was the most difficult aspect of their work. Consistently important was the need to better engage specific population groups, such as culturally and linguistically diverse people, pregnant people, at risk cohorts, and health care providers. Social and behavioural research about ‘how to effectively address hesitancy’ was ranked highly among participants.Conclusions: Findings from this project help provide an understanding of the behavioural, social, ethical, and policy knowledge needs for immunisation policy and implementation in Australia. To respond to vaccine challenges, increase coverage and build public trust in vaccination, policymakers and governments should incorporate social research into vaccination programmes.So What?: Australia is preparing to launch a Centre for Disease Control. This study demonstrates the importance of integrating social, behavioural, ethical, and policy research into the fabric of this new enterprise. It underlines the need to capacity‐build a workforce able to deliver high‐quality research in these areas, address the needs of immunisation implementers and policymakers, and achieve good outcomes for Australians.
- 3 June 2024
- Published by Wiley in Health Promotion Journal of Australia
- Vol. 36 (1)
Open AccessEvidence gaps and challenges in maintaining and increasing vaccine uptake: A Delphi survey with Australian stakeholders
Issue Addressed: Increasing and maintaining vaccination uptake is crucial for preventing and managing infectious diseases. In the context of the post‐coronavirus disease 2019 (COVID‐19) pandemic landscape, this paper examines the perceptions of immunisation implementers and policymakers to uncover the challenges and evidence gaps in routine immunisation efforts.Methods: We conducted an online two‐round modified Delphi survey with immunisation experts, senior public servants, policymakers, policy advisory groups, and representatives from peak bodies from across Australia. We asked respondents to outline what they see as the greatest challenges to increasing and maintaining uptake of recommended vaccines in Australia; the most difficult aspects of their work in vaccination; the largest evidence gaps in vaccine uptake; and the kinds of social and behavioural research they would like to see prioritised.Results: The two most important challenges for increasing and maintaining vaccine uptake were effectively communicating the benefits of vaccines to parents and the public and ensuring accessible and affordable vaccination services. Participants strongly agreed that ‘communication about the importance of vaccination’ was the most difficult aspect of their work. Consistently important was the need to better engage specific population groups, such as culturally and linguistically diverse people, pregnant people, at risk cohorts, and health care providers. Social and behavioural research about ‘how to effectively address hesitancy’ was ranked highly among participants.Conclusions: Findings from this project help provide an understanding of the behavioural, social, ethical, and policy knowledge needs for immunisation policy and implementation in Australia. To respond to vaccine challenges, increase coverage and build public trust in vaccination, policymakers and governments should incorporate social research into vaccination programmes.So What?: Australia is preparing to launch a Centre for Disease Control. This study demonstrates the importance of integrating social, behavioural, ethical, and policy research into the fabric of this new enterprise. It underlines the need to capacity‐build a workforce able to deliver high‐quality research in these areas, address the needs of immunisation implementers and policymakers, and achieve good outcomes for Australians.